Perspectives on returning to work of multiple myeloma patients: A qualitative interview study

被引:11
作者
Bennink, Christine [1 ,2 ]
van Der Klift, Marjolein [2 ]
Scheurer, Hans [3 ,4 ]
Sonneveld, Pieter [1 ]
Duijts, Saskia F. A. [5 ,6 ]
机构
[1] Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands
[2] Amphia Hosp, Dept Internal Med, Breda, Netherlands
[3] Myeloma Patients Europe MPE, Brussels, Belgium
[4] Hematon, Utrecht, Netherlands
[5] Netherlands Comprehens Canc Org, IKNL, Integraal Kankerctr Nederland, Dept Res & Dev, Utrecht, Netherlands
[6] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam, Netherlands
关键词
cancer; haematological malignancy; multiple myeloma; rare cancer; return to work; work disability; STEM-CELL TRANSPLANTATION; CANCER SURVIVORS; TO-WORK; EMPLOYMENT; COHORT;
D O I
10.1111/ecc.13481
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Multiple myeloma (MM) is a rare and incurable disease. Because new treatments improved survival rates, return to work (RTW) became more relevant to MM patients of working age. Also, (health care) experts may be confronted with specific obstacles in guiding MM patients' RTW. Therefore, we aimed to qualitatively explore perspectives and experiences of MM patients and (health care) experts regarding RTW and participation at work. Methods Semi-structured interviews were conducted with patients (N = 9) and (health care) experts (N = 15). Interviews were transcribed verbatim and analysed using thematic analysis. Results Four themes resulted from the interviews with patients and (health care) experts: (1) severity of diagnosis and treatment impact RTW, (2) step-by-step reintegration facilitates RTW, (3) meaning of work differs between MM patients and experts and (4) lack of tailored counselling by experts. Conclusion Although MM patients' work ability may be limited due to the severity of diagnosis and side effects from treatment, most patients consider RTW important. Both patients and (health care) experts emphasise the benefits from early work ability assessment (in the hospital setting) and specialised RTW counselling, especially in those with physically demanding jobs.
引用
收藏
页数:10
相关论文
共 20 条
[1]  
Braun V., 2006, Qualitative research in psychology, V3, P7, DOI [DOI 10.1080/14780887.2020.1769238, DOI 10.1191/1478088706QP063OA]
[2]   Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study [J].
Cavo, Michele ;
Gay, Francesca ;
Beksac, Meral ;
Pantani, Lucia ;
Petrucci, Maria Teresa ;
Dimopoulos, Meletios A. ;
Dozza, Luca ;
van der Holt, Bronno ;
Zweegman, Sonja ;
Oliva, Stefania ;
van der Velden, Vincent H. J. ;
Zamagni, Elena ;
Palumbo, Giuseppe A. ;
Patriarca, Francesca ;
Montefusco, Vittorio ;
Galli, Monica ;
Maisnar, Vladimir ;
Gamberi, Barbara ;
Hansson, Markus ;
Belotti, Angelo ;
Pour, Ludek ;
Ypma, Paula ;
Grasso, Mariella ;
Croockewit, Alexsandra ;
Ballanti, Stelvio ;
Offidani, Massimo ;
Vincelli, Iolanda D. ;
Zambello, Renato ;
Liberati, Anna Marina ;
Andersen, Niels Frost ;
Broijl, Annemiek ;
Troia, Rossella ;
Pascarella, Anna ;
Benevolo, Giulia ;
Levin, Mark-David ;
Bos, Gerard ;
Ludwig, Heinz ;
Aquino, Sara ;
Morelli, Anna Maria ;
Wu, Ka Lung ;
Boersma, Rinske ;
Hajek, Roman ;
Durian, Marc ;
Borne, Peter A. von dem ;
di Toritto, Tommaso Caravita ;
Zander, Thilo ;
Specchia, Giorgina ;
Waage, Anders ;
Gimsing, Peter ;
Mellqvist, Ulf-Henrik .
LANCET HAEMATOLOGY, 2020, 7 (06) :E456-E468
[3]   Work ability and return-to-work in cancer patients [J].
de Boer, A. G. E. M. ;
Verbeek, J. H. A. M. ;
Spelten, E. R. ;
Uitterhoeve, A. L. J. ;
Ansink, A. C. ;
de Reijke, T. M. ;
Kammeijer, M. ;
Sprangers, M. A. G. ;
van Dijk, F. J. H. .
BRITISH JOURNAL OF CANCER, 2008, 98 (08) :1342-1347
[4]  
Dinmohamed A, 2019, BELANGRIJKE CIJFERS
[5]   Sustained employability and health-related quality of life in cancer survivors up to four years after diagnosis [J].
Duijts, Saskia F. A. ;
Kieffer, Jacobien M. ;
van Muijen, Peter ;
van der Beek, Allard J. .
ACTA ONCOLOGICA, 2017, 56 (02) :174-182
[6]   Return to Work in Patients with Hematological Cancers 1 Year after Treatment: A Prospective Longitudinal Study [J].
Hartung, Tim J. ;
Sautier, Leon P. ;
Scherwath, Angela ;
Sturm, Kirsten ;
Kroeger, Nicolaus ;
Koch, Uwe ;
Mehnert, Anja .
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (11) :697-701
[7]   Wage-subsidised employment as a result of permanently reduced work capacity in a nationwide cohort of patients diagnosed with haematological malignancies [J].
Horsboel, Trine A. ;
Nielsen, Claus V. ;
Nielsen, Bendt ;
Andersen, Niels T. ;
De Thurah, Annette .
ACTA ONCOLOGICA, 2015, 54 (05) :743-749
[8]   Risk of disability pension for patients diagnosed with haematological malignancies: A register-based cohort study [J].
Horsboel, Trine A. ;
Nielsen, Claus V. ;
Andersen, Niels T. ;
Nielsen, Bendt ;
de Thurah, Annette .
ACTA ONCOLOGICA, 2014, 53 (06) :724-734
[9]   Type of hematological malignancy is crucial for the return to work prognosis: a register-based cohort study [J].
Horsboel, Trine Allerslev ;
Nielsen, Claus Vinther ;
Nielsen, Bendt ;
Jensen, Chris ;
Andersen, Niels Trolle ;
de Thurah, Annette .
JOURNAL OF CANCER SURVIVORSHIP, 2013, 7 (04) :614-623
[10]  
Integraal Kankercentrum Nederland (IKNL), 2019, MULTIPEL MYELOOM NED